Theratechnologies Inc. (TH.TO)

Toronto - Toronto Real Time Price. Currency in CAD

Add to watchlist

4.2100

+0.1200

(+2.93%)

At close: 03:59PM EST

Advertisement

Full screen

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	4.0900
Open	4.0100
Bid	4.2500 x 0
Ask	4.3000 x 0
Day's Range	4.0100 - 4.3000
52 Week Range	2.6800 - 5.6100
Volume	86,417
Avg. Volume	31,792

Market Cap	400.462M
Beta (5Y Monthly)	1.67
PE Ratio (TTM)	N/A
EPS (TTM)	-0.3970
Earnings Date	Feb 23, 2022 - Feb 28, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	4.76

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for TH.TO

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

News

Press Releases

GlobeNewswire
Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the "Life Sciences" Category
MONTREAL, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it was awarded of the 2021 Innovation Award in the “Life Sciences” category at the 31st ADRIQ Innovation Awards Gala held on November 25, 2021. Every year, the ADRIQ (Association pour le développement de la recherche et de l'innovation du Québec
CNW Group
Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be Extended
Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it has filed a preliminary short form base shelf prospectus with the securities regulatory authorities of all the provinces of Canada and a corresponding shelf registration statement with the United States Securities and Exchange Commission (the "SEC") on Form F-10.
GlobeNewswire
Theratechnologies to Present at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021
MONTREAL, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer, will present at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021 at 9:40 a.m. ET. A live webcast of the event can be accessed through the investor relations section of Theratechnologies’